Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenotypic Manifestations of Hereditary ATTR Amyloidosis Val50Met Variant in a Non-endemic Area. Descriptive Study

NCT07124377 is registered in ClinicalTrials.gov with Hospital 9 de Julio de Las Breñas as lead sponsor.

NCT NCT07124377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07124377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenotypic Manifestations of Hereditary ATTR Amyloidosis Val50Met Variant in a Non-endemic Area. Descriptive Study
Lead sponsor
Hospital 9 de Julio de Las Breñas
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2024
Completion date
March 1, 2027
Enrollment
57 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary amyloidosis, transthyretin-related